Prosecution Insights
Last updated: April 19, 2026
Application No. 18/038,338

Bioactive complexes

Non-Final OA §103
Filed
May 23, 2023
Examiner
PACKARD, BENJAMIN J
Art Unit
1612
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Ceradis Patent B V
OA Round
2 (Non-Final)
66%
Grant Probability
Favorable
2-3
OA Rounds
2y 11m
To Grant
82%
With Interview

Examiner Intelligence

Grants 66% — above average
66%
Career Allow Rate
869 granted / 1317 resolved
+6.0% vs TC avg
Strong +16% interview lift
Without
With
+16.1%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
44 currently pending
Career history
1361
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
44.2%
+4.2% vs TC avg
§102
18.6%
-21.4% vs TC avg
§112
14.5%
-25.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1317 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Applicants' arguments, filed 09/16/2025, have been fully considered. Rejections and/or objections not reiterated from previous office actions are hereby withdrawn. The following rejections and/or objections are either reiterated or newly applied. They constitute the complete set presently being applied to the instant application. Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claims 1-7 and 10-17 are rejected under 35 U.S.C. 103 as being unpatentable over Van Der Krieken et al (WO2013133705), in view of Ihara et al (Invert Neurosci (2008) 8:71–81). Van Der Krieken et al teaches compositions comprising a complex of a polyanion, such as lignosulfonate, and a polycation, such as chitosan, at a ratio of from 1:2 to 60:1 w/w%, and used to protect agricultural plant and plant parts against pathogens (Abstract and pg2 lines 11-19). The composition further includes biocides (pg 2 lines 21-26) where the complex is theorized to provide improved, longer lasting, adherence of the biocide to the plant. Among the insecticides is clothianidin, fosetyl-Al, etc. The process to make the conjugates is by mixing the polycation, such as chitosan, in an aqueous acidic solution, preferably below a pH of 4.5, where the polyanion is present from about 0.1-70w/v% and the polycation solution is present from about 0.1-10 w/v% (pg 3 lines 14-35). The particles are taught to be nano microsized, preferably to an average particle size of between 0.25 and 5 micrometers, then the biocide is added. Van Der Krieken et al does not teach the complex having the bioactive as the negatively charged component of the complex. Ihara et al teaches the ability to form complexes using salts of imidacloprid and clothianidin (Abstract). While Van Der Krieken et al focuses on the polyanions of lignosulfonate, the teaching is broader insofar as the teaching provides motivation to use any polyanions for the conjugates. As such, the skilled artisan would find it obvious to use anions known in the art and which are disclosed as suitable bioactives, and known to form conjugates, as taught by Ihara et al. Further, where the conjugates are known to be used to protect agricultural plant and plant parts against pathogens, it would have been obvious to one of ordinary skill in the art to apply them for controlling disease and preventing pathogens, based on the known activity of the bioactive agent. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to BENJAMIN J PACKARD whose telephone number is (571)270-3440. The examiner can normally be reached Mon 2-6pm and Tues-Fri (9am-6pm + mid-day flex). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sahana S. Kaup can be reached at (571) 272-6897. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BENJAMIN J PACKARD/ Primary Examiner, Art Unit 1612
Read full office action

Prosecution Timeline

May 23, 2023
Application Filed
Jun 12, 2025
Non-Final Rejection — §103
Sep 16, 2025
Response Filed
Jan 21, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12589111
PT(IV) CHEMOTHERAPEUTIC PRODRUG AND CONTROLLED RELEASE THEREOF FOR TREATMENT OF TUMORS
2y 5m to grant Granted Mar 31, 2026
Patent 12582745
ADHESIVE COMPOSITION FOR HARD TISSUE REPAIR
2y 5m to grant Granted Mar 24, 2026
Patent 12583865
Biologically Active Taxane Analogs and Methods of Treatment by Oral Administration
2y 5m to grant Granted Mar 24, 2026
Patent 12582586
Oral Care Compositions
2y 5m to grant Granted Mar 24, 2026
Patent 12576105
COMPOSITIONS FOR TREATING JOINT OR CONNECTIVE TISSUE DISEASE COMPRISING DEXTRAN OR POLOXAMER
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

2-3
Expected OA Rounds
66%
Grant Probability
82%
With Interview (+16.1%)
2y 11m
Median Time to Grant
Moderate
PTA Risk
Based on 1317 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month